{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T20:52:41Z","timestamp":1784235161941,"version":"3.55.0"},"reference-count":28,"publisher":"FapUNIFESP (SciELO)","issue":"1","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Gastroenterol."],"abstract":"<jats:p>ABSTRACT BACKGROUND: Worldwide, colorectal cancer (CRC) and gastric cancer (GC) are the third and the fifth most prevalent, respectively. Diarrhea is a common symptom in patients on chemotherapy or radiotherapy treatment and can reduce treatment tolerance. Surgical resections and chemotherapy change the intestinal microbiota that can lead to lactose intolerance, small intestinal bacterial overgrowth (SIBO). OBJECTIVE: The aim of the study was to evaluate the frequency of diarrhea in patients with CRC and GC on chemotherapy with SIBO or intolerance of lactose. METHODS: This is a descriptive and observational study with patients of both sexes, over 18 years old, in treatment in the Gastro-Oncology outpatient clinic of the Federal University of S\u00e3o Paulo. Patients with a confirmed diagnosis of CRC or GC during chemotherapy treatment were included. To detect bacterial overgrowth and lactose intolerance, breath hydrogen test with lactulose and lactose was done. Number and aspects of the evacuations and toxicity degree were collected. For the nutritional assessment, weight and height were performed to calculate the BMI. and the Patient Generated Subjective Global Assessment (PG-SGA). RESULTS: A total of 33 patients were included, 29 with CRC and 3 with GC. Most of them were male (57.57%), mean age of 60.03\u00b110.01 years and in chemotherapy with fluoropyrimidine and oxaliplatin (54.5%). Diarrhea was present in 57.6% and 30.3% had toxicity grade 2. According to the BMI, 78.9% were eutrophics, obese or overweight, but according to PG-SGA, 84.9% had moderate or severe nutritional risk grade. Between patients, 45% had lactose intolerance and 9% SIBO. Diarrhea grade 2-3 was observed in 66.6% of patients with SIBO and 66.7% of that with lactose intolerance. No statistical difference was observed between patients with SIBO or lactose intolerance and grade of diarrhea. CONCLUSION: Diarrhea was a frequent symptom in chemotherapy patients with gastric or colorectal cancer independent of the presence of SIBO or lactose intolerance. Surgery and chemotherapy treatment impacted in the intestinal habit of patients. Diagnosis of other causes of diarrhea may contribute to a better tolerance to treatment and quality of life.<\/jats:p>","DOI":"10.1590\/s0004-2803.202100000-06","type":"journal-article","created":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T12:26:21Z","timestamp":1619180781000},"page":"26-31","source":"Crossref","is-referenced-by-count":2,"title":["NONINVASIVE BREATH TESTS FOR DIAGNOSIS OF SIBO AND LACTOSE INTOLERANCE IN PATIENTS ON CHEMOTHERAPY TREATMENT FOR COLORECTAL AND GASTRIC C\u00c2NCER"],"prefix":"10.1590","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4313-7704","authenticated-orcid":false,"given":"Aline Rufino","family":"GON\u00c7ALVES","sequence":"first","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3318-6246","authenticated-orcid":false,"given":"Orlando","family":"AMBROGINI JR","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9414-0343","authenticated-orcid":false,"given":"Nora Manoukian","family":"FORONES","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2021,3]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"68","author":"Bray F","year":"2018","journal-title":"Cancer J Clin"},{"key":"ref2","series-title":"Incid\u00eancia de C\u00e2ncer no Brasil Estimativa 2020","year":"2020"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1080\/0284186X.2017.1304650","article-title":"Descriptive Characteristics of Colon and Rectal Cancer Recurrence in Danish Population Based-Study","volume":"56","author":"Holmes AC","year":"2017","journal-title":"Acta Oncologica"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s40273-013-0081-2","article-title":"The economic burden of toxicities associated with cancer treatment: review of the literature and analysis of nausea and vomiting, diarrhea, oral mucositis and fatigue","volume":"31","author":"Carlotto A","year":"2013","journal-title":"Pharmacoeconomics"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(14)70006-3","article-title":"Guidance on the management of diarrhoea during cancer chemotherapy","volume":"15","author":"Andreyev J","year":"2014","journal-title":"Lancet Oncol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1200\/JCO.2004.04.132","article-title":"Recommended Guidelines for the Treatment of Cancer Treatment-Induced Diarrhea","volume":"22","author":"Benson AB","year":"2004","journal-title":"J Clin Oncol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"240","DOI":"10.7861\/clinmedicine.16-3-240","article-title":"The Holistic Management of Consequences of Cancer Treatment by a Gastrointestinal and Nutrition Team: A Financially Viable Approach to an Enormous Problem?","volume":"16","author":"Muls AC","year":"2016","journal-title":"Clin Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1080\/0284186X.2018.1562211","article-title":"Clinical Evaluation and Treatment of Chronic Bowel Symptoms Following Cancer in Colon and Pelvic Organs","volume":"58","author":"Larsen HM","year":"2019","journal-title":"Acta Oncologica"},{"key":"ref9","first-page":"1","article-title":"Cachexia Stage, Patient-Generated Subjective Global Assessment, Phase Angle, and Handgrip Strength in Patients with Gastrointestinal Cancer","volume":"19","author":"Ozorio GA","year":"2017","journal-title":"Nutr Cancer"},{"key":"ref10","first-page":"544","article-title":"Validation of Nutritional Risk Index Method Against Patient Generated Subjective Global Assessment in Screening Malnutrition in Colorectal Cancer Patients","volume":"25","author":"Faramarzi E","year":"2013","journal-title":"Chin. F. Cancer Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11894-015-0482-9","article-title":"How to Test and Treat Small Intestinal Bacterial Overgrowth: An Evidence-Based Approach","volume":"18","author":"Rezaie A","year":"2016","journal-title":"Curr Gastroenterol Rep"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41424-018-0011-x","article-title":"Does Colectomy Predispose to Small Intestinal Bacterial (SIBO) and Fungal Overgrowth (SIFO)?","volume":"9","author":"Rao SS","year":"2018","journal-title":"Clin Transl Gastroenterol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3109\/0284186X.2013.873140","article-title":"Gastrointestinal consequences of cancer treatment and the wider context: A bad gut feeling","volume":"53","author":"Muls AC","year":"2014","journal-title":"Acta Oncol"},{"key":"ref14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046520","article-title":"Several Different Lactase Persistence Associated Alleles and High Diversity of the Lactase Gene in the Admixed Brazilian Population","volume":"7","author":"Friedrich DC","year":"2012","journal-title":"PLoS One"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/bjc.2014.544","article-title":"Lactose Intolerance and Risk of Lung, Breast and Ovarian Cancers: Aetiological Clues from a Population-Based Study in Sweden","volume":"112","author":"Ji J","year":"2015","journal-title":"Br J Cancer"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3393\/ac.2017.33.5.157","article-title":"Lactose Intolerance and Colorectal Cancer","volume":"33","author":"Kim JW","year":"2017","journal-title":"Ann Coloproctol"},{"key":"ref17","series-title":"Common Terminology Criteria for Adverse Events (CTCAE)","year":"2017"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3109\/00365529709011203","article-title":"Stool Form Scale as a Useful Guide to Intestinal Transit Time","volume":"32","author":"Lewis SJ","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5056\/jnm19113","article-title":"Breath Tests for the Non-invasive Diagnosis of Small Intestinal Bacterial Overgrowth: A Systematic Review With Meta-analysis","volume":"26","author":"Losurdo G","year":"2020","journal-title":"J Neurogastroenterol Motil"},{"key":"ref20","series-title":"Obesity: Preventing and Managing the Global Epidemic: Report of WHO Consultation on Obesity","year":"1997"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0095-4543(21)00452-8","article-title":"Screening for Nutrition Status in Elderly","volume":"21","author":"Lipschitz DA","year":"1994","journal-title":"Prime Care"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1200\/JCO.2006.08.1075","article-title":"Phase III Trial of Capecitaine plus Oxaliplatine as adjuvante therapy for Stage III Colon Cancer: A Planned Safety Analysis in 1864 Patients","volume":"25","author":"Schmoll HJ","year":"2007","journal-title":"J Clin Oncol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/annonc\/mdj052","article-title":"The integration of oral capecitabine into chemoradiation regimens for locally advanced rectal cancer: how successful have we been?","volume":"17","author":"Glynne-Jones R","year":"2006","journal-title":"Ann Oncol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1046\/j.1365-2362.1997.1200674.x","article-title":"Small Bowel Bacterial Overgrowth in Patients After Total Gastrectomy","volume":"27","author":"Br\u00e4gelmann R","year":"1997","journal-title":"Eur J Clin Invest"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1064029","DOI":"10.1155\/2016\/1064029","article-title":"Lactulose Hidrogen Breath Test Result is Associated with Age and Gender","volume":"2016","author":"Newberry C","year":"2016","journal-title":"Biomed Res Int"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-09964-7","article-title":"Small Intestinal Microbial Dysbiosis Underlies Symptoms Associated with Functional Gatrointestinal Disorders","volume":"10","author":"Saffouri GB","year":"2019","journal-title":"Nat Commun"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"227","DOI":"10.5152\/tjg.2016.15375","article-title":"Effect of Probiotics on Small Intestinal Bacterial Overgrowth in Patients with Gastric and Colorectal Cancer","volume":"27","author":"Liang S","year":"2016","journal-title":"Turk J Gastroenterol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S1542-3565(04)00293-9","article-title":"Lactose Intolerance Associated with Adjuvant S-Fluourouracil-Based Chemotherapy for Colorectal Cancer","volume":"2","author":"Osterlund P","year":"2004","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Arquivos de Gastroenterologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/ag\/v58n1\/1678-4219-ag-58-01-26.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,25]],"date-time":"2022-12-25T08:49:32Z","timestamp":1671958172000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-28032021000100026&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,3]]}},"alternative-id":["S0004-28032021000100026"],"URL":"https:\/\/doi.org\/10.1590\/s0004-2803.202100000-06","relation":{},"ISSN":["1678-4219","0004-2803"],"issn-type":[{"value":"1678-4219","type":"electronic"},{"value":"0004-2803","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]}}}